Aclipse Therapeutics focuses on developing differentiated drugs to address diseases with unmet medical needs.
Aclipse Therapeutics has raised $1.5M in total funding. The most recent round was Grant. The last funding was announced in April 2022.
Aclipse Therapeutics's investors include U.S. Department of War, Medical Research Council, Intellectual Digital Global (iDG), FightMND, Intellectual Digital Corp. (iDC).
Aclipse Therapeutics is headquartered in Radnor, United States.
Aclipse Therapeutics focuses on developing differentiated drugs to address diseases with unmet medical needs.
Aclipse Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aclipse Therapeutics — Funding & Investors." VCBacked, April 20, 2022, https://www.vcbacked.co/company/aclipse-therapeutics. Accessed September 14, 2026.
VCBacked. (2022). Aclipse Therapeutics — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/aclipse-therapeutics
{{cite web |title=Aclipse Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aclipse-therapeutics |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated